Book a package for Bone Marrow Transplant Allogenic in India | HCH
Bone Marrow Transplant Allogenic, India

Bone Marrow Transplant Allogenic, India

Bone Marrow Transplant Allogenic


  • Our Price USD 24930

  • Hospital Price USD 27700

  • You Save : USD 2770

Booking Amount: USD 2493. Pay Remaining 90% at the hospital.

Book Now

Additional Credit

Among the important extras we offer as part of the Additional Credit are the following:

  • Site Tourism For The Patient & Attendant
  • Airport Pick & Drop Service
  • Ambulance service at airport
  • Priority appointments with The Doctor
  • Cancel Easily Anytime with Full Refund
  • Room Upgradation
  • Free Online Doctor Consultation Valued at USD 20
  • Free hotel Stay for 5 to 7 days Accordingly
  • Welcome Kit at Arrival
  • Interpreter
  • Medical Visa Assistance

  • Doctor consultation charges
  • Lab tests and diagnostic charges
  • Room charges inside hospital during the procedure
  • Surgeon Fee
  • Cost of implant
  • Nursing charges
  • Hospital surgery suite charges
  • Anesthesia charges
  • Routine medicines and routine consumables (bandages, dressings etc.)
  • Food and Beverages inside hospital stay for patient and one attendant.

  • Extra Radiology Investigations
  • Healthcare Professionals Charges of other consultations.
  • Other Requested Services such as Laundry etc.
  • Additional Pharmaceutical Products and Medicines After Discharge from Hospital.
  • Management of Conditions Unrelated to Procedures or Pre-Existing.
  • The cost of any additional implants will be in addition to the package cost.

Bone Marrow Transplant Allogenic

A method in which healthy blood-forming cells are given to a patient to replace their own blood forming cells that have been damaged by radiation or heavy doses of chemotherapy.

Disease Overview:

Bone marrow cancer

Malignant plasma cells in bone marrow develop bone marrow cancer, also known as multiple myeloma, which spreads throughout the body.

Multiple myeloma is a malignancy that develops in the plasma cells of white blood cells. Antibodies that detect and destroy germs are produced by healthy plasma cells, which aid in the battle against infections.

Cancerous plasma cells grow in the bone marrow and drive out healthy blood cells in multiple myeloma. Instead of producing beneficial antibodies, cancer cells create aberrant proteins that might cause problems.

Multiple myeloma treatment isn't always required right away. Your doctor may prescribe diligent monitoring instead of early treatment if the multiple myeloma is slow developing and not causing signs and symptoms. There are a variety of therapeutic choices for patients with multiple myeloma who need help controlling the disease.

Disease Signs and Symptoms:

Multiple myeloma symptoms and signs vary, and there may be none at all early on in the disease.

When signs and symptoms do appear, they may include the following:

  • Bone discomfort, particularly in the spine and chest
  • Nausea
  • Constipation
  • Appetite loss.
  • Confusion or mental fogginess
  • Fatigue
  • Infections that occur frequently
  • Loss of weight
  • Leg numbness or a feeling of weakness
  • Thirst that is excessive

Disease Causes:

It is unknown what causes myeloma.

Myeloma is thought to start with a single aberrant plasma cell in your bone marrow, which is the soft, blood-producing tissue that fills the middle of most of your bones. The aberrant cell proliferates quickly.

Because cancer cells do not mature and subsequently die like regular cells, they collect and eventually outnumber healthy cell creation. Myeloma cells squeeze out healthy blood cells in the bone marrow, causing exhaustion and an inability to fight infections.

Myeloma cells, like healthy plasma cells, continue to try to make antibodies, but they generate aberrant antibodies that the body can't employ. Instead, aberrant antibodies (monoclonal proteins, or M proteins) accumulate in the body, causing issues such as kidney damage. Cancer cells can also cause bone deterioration, increasing the chance of breaking a bone.

A relationship with MGUS

Almost all cases of multiple myeloma begin as a relatively benign illness known as monoclonal gammopathy of unknown significance (MGUS).

MGUS, like multiple myeloma, is identified by the presence of M proteins in your blood, which are generated by abnormal plasma cells. However, with MGUS, M protein levels are reduced, and no harm to the body occurs.

Factors that are at risk

  • Multiple myeloma can be caused by a number of factors, including:
  • Getting older. Multiple myeloma is more common as you become older, with most people being diagnosed in their mid-60s.
  • Sex of a man. Men are more prone than women to get the condition.
  • The race of black people. Persons of colour are more likely than people of other races to acquire multiple myeloma.
  • Multiple myeloma runs in the family. You have a higher chance of developing multiple myeloma if a sibling, sister, or parent has the disease.
  • Personal experience with a monoclonal gammopathy of unknown relevance (MGUS). MGUS usually always precedes multiple myeloma, therefore having this condition doubles your risk.

Disease Diagnosis:

When your doctor finds multiple myeloma by mistake during a blood test for another ailment, it is called multiple myeloma. If your doctor believes you have multiple myeloma based on your signs and symptoms, it can be diagnosed.

The following tests and procedures are used to diagnose multiple myeloma:

Tests on the blood. Myeloma cells generate M proteins, which can be detected with a blood test. Beta-2-microglobulin, an aberrant protein generated by myeloma cells, may be discovered in your blood and provide your doctor with information regarding the aggressiveness of your myeloma.

Blood tests to check renal function, blood cell counts, calcium levels, and uric acid levels can also help your doctor figure out what's wrong with you.

Urine tests are performed. When M proteins, also known as Bence Jones proteins, are identified in urine, they are referred to as Bence Jones proteins.

Your bone marrow will be examined. A sample of bone marrow may be taken for laboratory testing by your doctor. A large needle is put into a bone to collect the sample (bone marrow aspiration and biopsy).

The sample is tested in the lab for myeloma cells. Specialized techniques, such as fluorescence in situ hybridization (FISH), can discover gene alterations in myeloma cells.

Imaging tests are performed. Bone issues linked with multiple myeloma may necessitate imaging testing. X-rays, MRIs, CT scans, and positron emission tomography are some of the tests that may be performed (PET).

Disease Treatment:

Treatment can help reduce pain, control illness complications, stabilize your health, and limit the progression of multiple myeloma if you're suffering symptoms.

It's possible that immediate therapy isn't required.

If you have multiple myeloma but no symptoms (also known as smouldering multiple myeloma), you may not require immediate treatment. Multiple myeloma that is slow developing and in its early stages may not require immediate therapy. Your doctor will, however, keep a close eye on your situation for indicators of illness progression. This might include blood and urine testing on a regular basis.

You and your doctor may decide to start treatment if you develop signs and symptoms or if your multiple myeloma shows evidence of progression.

Myeloma treatment options

The following are examples of standard treatment options:

Therapy that is specific to the patient. Targeted medication therapies concentrate on particular flaws seen in cancer cells. Targeted medication therapies can kill cancer cells by inhibiting these aberrations.

Immunotherapy. Immunotherapy is a type of cancer treatment that makes use of your immune system. Because cancer cells create proteins that assist them hide from immune system cells, your body's disease-fighting immune system may not attack your cancer. Immunotherapy works by interfering with the immune system's natural processes.

Chemotherapy. Chemotherapy is a treatment that employs chemicals to destroy cancer cells. Fast-growing cells, such as myeloma cells, are killed by the medications. Before a bone marrow transplant, high dosages of chemotherapy medicines are utilized.

Corticosteroids. Corticosteroid drugs manage inflammation in the body by regulating the immune system. They're also good in killing myeloma cells.

Transplantation of bone marrow. A bone marrow transplant is a treatment that replaces damaged bone marrow with healthy bone marrow.

Blood-forming cells are taken from your blood before a bone marrow transplant. The damaged bone marrow is subsequently destroyed with large doses of chemotherapy. The blood forming cells are then injected into your body, where they go to your bones and begin the process of rebuilding your bone marrow.

Radiation therapy is a type of treatment that involves the use of To destroy cancer cells, radiation treatment employs high-powered energy beams from sources such as X-rays and protons. It can be used to diminish myeloma cells in a specific location fast, such as when a cluster of aberrant plasma cells forms a tumor (plasmacytoma) that causes discomfort or destroys a body part.

Information related to Treatment

Package Details

Days in Hospital
30 Days

Days in Hotel *
60 Days

Room Type

* Including Complimentary Hotel Stay for 1 nights for 2 (Patient and 1 Companion)
Dr Mitu Shrikhande

Treating Doctor

Dr Mitu Shrikhande

Hematologist- Blood transfusion, Bone marrow transplant, Chelation therapy, Haemophilia, Lymphatic drainage, Stem cell transplantation, Thallessemia

Fortis Flt. Lt. Rajan Dhall Hospital, Vasant Kunj, Delhi New Delhi, India

26 Years of Experience

Dr. Pawan Kumar Singh

Treating Doctor

Dr. Pawan Kumar Singh

Oncologist,Hematologist- Hematologist-oncologist, Hepatitis Specialist, HIV Specialist, Thalassaemia, Bone marrow and cell transplantation, Sickle Cell Disease

Shalby Sanar International Hospital Gurgaon, India

15 Years of Experience

Dr. Meet Kumar

Treating Doctor

Dr. Meet Kumar

Oncologist,Hematologist- Hematologist-oncologist, Blood Cancer Specialist, Blood transfusion, Bone marrow transplant, Thalassaemia, Bone marrow and cell transplantation, Bone marrow transplant

Marengo Asia hospital, Faridabad Faridabad, India

14 Years of Experience

Dr. Ashok Vaid

Treating Doctor

Dr. Ashok Vaid

Medical Oncologist- Medical oncology, Bone marrow transplant

Medanta-The Medicity, Gurgaon Gurgaon, India

32 Years of Experience

Artemis Hospitals Gurgaon

Treating Doctor

Artemis Hospitals Gurgaon

Radiation Oncologist- Bone marrow transplant, Stem Cell Transplant, Blood Cancer Treatment, Sickle Cell Disease, Radiosurgery

Artemis Hospitals Gurgaon, India

44 Years of Experience

Dr. Sunil Kumar Gupta

Treating Doctor

Dr. Sunil Kumar Gupta

Medical Oncologist- Stem cell transplantation, Solid Tumors, Chemotherapy Treatment, Solid and Haematological Cancers, Bone Marrow Transplant (BMT)

Venkateshwar Hospital New Delhi, India

35 Years of Experience

Dr. Uma Dangi

Treating Doctor

Dr. Uma Dangi

Medical Oncologist- Gynecologic oncology, Leukemia Specialist, Breast Cancer, Gastrointestinal Cancer, Solid Tumors, Multiple myeloma, Blood Cancer, Chemotherapy, Acute Lymphoblastic Leukemia, Lung Tumours

Fortis Hiranandani Hospital, Vashi Navi Mumbai, India

15 Years of Experience

Dr. Sirisha Rani

Treating Doctor

Dr. Sirisha Rani

Pediatric Oncologist- Pediatric oncologist, Pediatric Hematology-Oncology, Bone marrow transplant, Bone marrow transplant, Bone marrow transplant

Rainbow Children's Hospital and BirthRight by Rainbow, Hyderabad Hyderabad, India

25 Years of Experience

Dr. M. Chandrashekar

Treating Doctor

Dr. M. Chandrashekar

Surgical oncologist- Bone marrow transplant, Bone marrow transplant, Chemotherapy, Chemotherapy, Bone marrow transplant, Solid and Haematological Cancers, Stem Cell Transplant, Chemotherapy

Apollo Hospital (Bannerghatta Road) Bangalore Bengaluru, India

46 Years of Experience

Dr. Mallikarjun Kalashetty

Treating Doctor

Dr. Mallikarjun Kalashetty

Surgical oncologist,Hematologist- Non Healing Ulcers, Intra - Arterial Thrombolysis, Bone marrow transplant, Rheumatology, Bone marrow transplant, Blood Cancer, Hodgkins Lymphomas, Acute Lymphoblastic Leukemia, Leukaemia and multiple myeloma, End-Stage Renal Disease, Bone marrow transplant, Blood Cancer, Sickle Cell Disease, Blood Cancer, End-Stage Renal Disease

Manipal Hospital (Old Airport Road) Bangalore Bengaluru, India

32 Years of Experience

Similar Packages

Bone Marrow Transplant Allogenic

Bone Marrow Transplant Allogenic

Start from

$27700 $24930

@ 10%% off
Book @0%
Bone Marrow Transplant Allogenic

Bone Marrow Transplant Allogenic

Start from

$60702 $57667

@ 5%% off
Book @0%
Bone Marrow Transplant Allogenic

Bone Marrow Transplant Allogenic

Start from

$51702 $49117

@ 5%% off
Book @0%

Frequently Asked Questions

In India, bone marrow surgery is provided by roughly 34 hospitals, some of which are mentioned below: Medanta - The Medicity, Gurgaon; Artemis Health Institute, Gurgaon; Global Health City, Chennai; Max Super Speciality Hospital, Saket; and Sterling Wockhardt Hospital, Mumbai

After surgery, patients often stay in the hospital for 30 days on average to receive the necessary care and monitoring. It's crucial that the patient recovers appropriately and feels at ease following the procedure within this time range. It is established through a battery of tests that the patient is doing well following surgery and can be released.

The patient's recovery differs based on multiple circumstances. Nonetheless, following discharge, a patient is expected to remain in the nation for roughly 90 on average. To be sure the procedure went well, this is crucial. Control and follow-up exams are conducted during this period to ensure medical fitness.

India's bone marrow transplant hospitals have an average rating of 5.0. This ranking is determined by taking into account a number of factors, including infrastructure, service quality, personnel politeness, and hygiene.

The type of bone marrow transplant performed and the ailment being treated are the two primary factors that determine the precise cost of a bone marrow transplant in India. In India, the typical cost of an autologous bone marrow transplant begins at about $18,000. Conversely, the starting cost of an allogeneic transplant in India is about $28,000. An allogeneic transplant may be suggested or carried out under specific circumstances.

The following medical professionals are among the top bone marrow transplant specialists in India: Gurgaon's Sanar International Hospital's Dr. Dharma Chaudhary Dr. P Anoop from Bangalore's Global Hospital Amrita Hospital, Faridabad; Dr. Pravas Chandra Mishra

Enquire Now